Previous Section
Review Articles
11. Iron overload in myelodysplastic syndromes.
- Author
- Mahesh S; Ginzburg Y; Verma A;
- Institution
- Albert Einstein College of Medicine, Cancer Center, Bronx, NY, USA.
- Journal
- Leuk Lymphoma. 2008 Mar;49(3):427-38.
- Abstract URL
- Click here to view abstract
12. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
- Author
- Niemeyer CM; Kratz CP;
- Institution
- Department of Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany. charlotte.niemeyer@uniklinik-freiburg.de
- Journal
- Br J Haematol. 2008 Mar;140(6):610-24.
- Abstract URL
- Click here to view abstract
13. Hematopoietic cell transplantation for patients with myelodysplastic syndromes (MDS): when, how and for whom?
- Author
- Marcondes M; Deeg HJ;
- Institution
- Fred Hutchinson Cancer Research Center and the University of Washington, 1100 Fairview Avenue North, D1-100, PO Box 19024, Seattle, WA 98109-1024, USA.
- Journal
- Best Pract Res Clin Haematol. 2008 Mar;21(1):67-77.
- Abstract URL
- Click here to view abstract
14. Supportive care, growth factors, and new therapies in myelodysplastic syndromes.
- Author
- Hellstrom-Lindberg E; Malcovati L;
- Institution
- Karolinska Institutet, Department of Medicine, Division of Hematology, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden. Eva.Hellstrom-Lindberg@ki.se
- Journal
- Blood Rev. 2008 Mar;22(2):75-91. Epub 2008 Feb 20.
- Abstract URL
- Click here to view abstract
15. Myelodysplastic syndromes in children: a critical review of issues in the diagnosis and classification of 887 cases from 13 published series.
- Author
- Elghetany MT;
- Institution
- Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0743, USA. melgheta@utmb.edu
- Journal
- Arch Pathol Lab Med. 2007 Jul;131(7):1110-6.
- Abstract URL
- Click here to view abstract
16. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia.
- Author
- Wood BL;
- Institution
- Hematopathology Laboratory, Box # 357110, Department of Laboratory Medicine, University of Washington Medical Center, 1959 NE Pacific Street, Seattle, WA 98195, USA. woodbl@u.washington.edu
- Journal
- Clin Lab Med. 2007 Sep;27(3):551-75, vii.
- Abstract URL
- Click here to view abstract
17. Use of hypomethylating agents in myelodysplastic syndromes.
- Author
- Atallah E; Garcia-Manero G;
- Institution
- Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
- Journal
- Clin Adv Hematol Oncol. 2007 Jul;5(7):544-52.
- Abstract URL
- Click here to view abstract
18. Immunomodulatory drugs in the treatment of myelodysplastic syndromes.
- Author
- Ortega J; List A;
- Institution
- Department of Interdisciplinary Oncology, University of South Florida, College of Medicine and the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9497, USA.
- Journal
- Curr Opin Oncol. 2007 Nov;19(6):656-9.
- Abstract URL
- Click here to view abstract
19. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
- Author
- Valcarcel D; Martino R; Valcarcel D; Martino R;
- Institution
- Division of Clinical Hematology, Hospital de la Sant Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain. dvalcarcel@santpau.es
- Journal
- Curr Opin Oncol. 2007 Nov;19(6):660-6.
- Abstract URL
- Click here to view abstract
20. Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.
- Author
- Kerbauy DB; Deeg HJ;
- Institution
- Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, WA 98109-1024, USA.
- Journal
- Exp Hematol. 2007 Nov;35(11):1739-46.
- Abstract URL
- Click here to view abstract
